Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 6 | BMC Genomic Data

Fig. 6

From: TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma

Fig. 6

Synergistic prognostic effects of CCNE1 with age at diagnosis in neuroblastoma. a Box plots showing the relative CCNE1 mRNA expression levels in paediatric neuroblastoma patients with an age at diagnosis ≥ 18 months or < 18 months in the TARGET, E-MTAB-161, E-MTAB-1781, E-MTAB-8248, E-TABM-38, GSE16476, GSE49710 and GSE85047 datasets. b Paediatric neuroblastoma patients were divided into four subgroups based on the expression levels of CCNE1 and age of diagnosis. Different overall survival rates of paediatric neuroblastoma patients in each subgroup were determined

Back to article page

BMC Genomic Data

ISSN: 2730-6844

Contact us